Logo image of CRL

CHARLES RIVER LABORATORIES (CRL) Stock Analyst Earnings Estimates

NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD

166.91  -2.73 (-1.61%)

After market: 166.91 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
CRL revenue by date.CRL revenue by date.
3.976B
12.31%
4.129B
3.86%
4.05B
-1.92%
3.938B
-2.77%
4.036B
2.49%
4.243B
5.13%
4.42B
4.17%
4.431B
0.25%
4.593B
3.66%
4.794B
4.38%
5.012B
4.55%
EBITDA
YoY % growth
CRL ebitda by date.CRL ebitda by date.
963.585M
7.24%
973.446M
1.02%
912.573M
-6.25%
998.78M
9.45%
1.026B
2.73%
1.128B
9.94%
1.112B
-1.42%
1.162B
4.50%
1.238B
6.54%
1.333B
7.67%
1.451B
8.85%
EBIT
YoY % growth
CRL ebit by date.CRL ebit by date.
659.715M
4.22%
659.322M
-0.06%
550.832M
-16.45%
740.79M
34.49%
747.89M
0.96%
795.58M
6.38%
913.27M
14.79%
957.28M
4.82%
N/AN/AN/A
Operating Margin
CRL operating margin by date.CRL operating margin by date.
16.59%15.97%13.60%18.81%18.53%18.75%20.66%21.60%N/AN/AN/A
EPS
YoY % growth
CRL eps by date.CRL eps by date.
11.13
7.74%
10.65
-4.31%
10.32
-3.10%
9.70
-6.05%
10.36
6.85%
11.32
9.28%
12.44
9.84%
13.29
6.88%
14.11
6.16%
29.52
109.23%
N/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
2.52
-9.91%
2.40
-7.32%
2.44
-8.13%
2.56
9.51%
2.65
5.03%
2.66
10.75%
2.74
12.32%
2.68
4.45%
2.81
6.16%
3.05
14.73%
3.27
19.21%
Revenue
Q2Q % growth
994.91M
-3.04%
970.23M
-3.92%
974.35M
-2.81%
1.008B
2.42%
1.017B
2.22%
1.02B
5.13%
1.03B
5.71%
1.078B
6.94%
1.078B
6.00%
1.112B
9.02%
1.155B
12.14%
EBITDA
Q2Q % growth
249.98M
-26.70%
240.35M
-41.05%
242.18M
-46.41%
255.16M
16.58%
269.84M
7.94%
266.68M
10.95%
271.26M
12.01%
286.95M
12.46%
296.42M
9.85%
314.62M
17.98%
331.37M
22.16%
EBIT
Q2Q % growth
186.58M
10.01%
177.15M
19.65%
178.02M
97.37%
181.38M
84.12%
204.55M
9.63%
202.8M
14.48%
208.28M
17.00%
200.18M
10.36%
219.63M
7.37%
213.26M
5.16%
217.02M
4.20%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
2.34
3.08%
2.100.2411.44%
Q4 2024
Q2Q % growth
2.66
8.13%
2.560.104.03%
Q3 2024
Q2Q % growth
2.59
-4.78%
2.450.145.70%
Q2 2024
Q2Q % growth
2.80
4.09%
2.420.3815.80%
Q1 2024
Q2Q % growth
2.27
-18.35%
2.090.188.63%
Q4 2023
Q2Q % growth
2.46
-17.45%
2.430.031.38%
Q3 2023
Q2Q % growth
2.72
3.42%
2.390.3313.71%
Q2 2023
Q2Q % growth
2.69
-2.89%
2.660.030.95%
Q1 2023
Q2Q % growth
2.78
1.09%
2.610.176.34%
Q4 2022
Q2Q % growth
2.98
19.68%
2.770.217.46%
Q3 2022
Q2Q % growth
2.63
-2.59%
2.520.114.37%
Q2 2022
Q2Q % growth
2.77
6.13%
2.760.010.30%
Q1 2022
Q2Q % growth
2.75
8.70%
2.740.010.26%
Q4 2021
Q2Q % growth
2.49
4.18%
2.460.031.35%
Q3 2021
Q2Q % growth
2.70
15.88%
2.600.103.70%
Q2 2021
Q2Q % growth
2.61
65.19%
2.400.218.57%
Q1 2021
Q2Q % growth
2.53
37.50%
2.210.3214.27%
Q4 2020
Q2Q % growth
2.39
18.91%
2.130.2612.40%
Q3 2020
Q2Q % growth
2.33
37.87%
1.820.5128.20%
Q2 2020
Q2Q % growth
1.58
-3.07%
1.280.3023.72%
Q1 2020
Q2Q % growth
1.84
31.43%
1.500.3422.89%
Q4 2019
Q2Q % growth
2.01 1.850.168.48%
Q3 2019
Q2Q % growth
1.69 1.650.042.50%
Q2 2019
Q2Q % growth
1.63 1.570.063.90%
Q1 2019
Q2Q % growth
1.40 1.400.000.33%
CRL Yearly EPS VS EstimatesCRL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20 25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
984.168M
-2.71%
951.39M32.778M3.45%
Q4 2024
Q2Q % growth
1.003B
-1.08%
993.46M9.089M0.91%
Q3 2024
Q2Q % growth
1.01B
-1.64%
985.77M23.993M2.43%
Q2 2024
Q2Q % growth
1.026B
-3.19%
1.035B-8.883M-0.86%
Q1 2024
Q2Q % growth
1.012B
-1.73%
1.002B9.56M0.95%
Q4 2023
Q2Q % growth
1.013B
-7.85%
1.001B12.476M1.25%
Q3 2023
Q2Q % growth
1.027B
3.79%
1.011B15.623M1.55%
Q2 2023
Q2Q % growth
1.06B
8.92%
1.064B-4.063M-0.38%
Q1 2023
Q2Q % growth
1.029B
12.63%
996.21M33.163M3.33%
Q4 2022
Q2Q % growth
1.1B
21.52%
1.045B54.843M5.25%
Q3 2022
Q2Q % growth
989.157M
10.40%
980.14M9.017M0.92%
Q2 2022
Q2Q % growth
973.131M
6.40%
1.005B-31.869M-3.17%
Q1 2022
Q2Q % growth
913.929M
10.83%
919.21M-5.281M-0.57%
Q4 2021
Q2Q % growth
905.05M
14.42%
897.16M7.89M0.88%
Q3 2021
Q2Q % growth
895.937M
20.54%
912.23M-16.293M-1.79%
Q2 2021
Q2Q % growth
914.607M
33.99%
889.25M25.357M2.85%
Q1 2021
Q2Q % growth
824.6M
16.62%
806.16M18.44M2.29%
Q4 2020
Q2Q % growth
791M
14.46%
764.43M26.57M3.48%
Q3 2020
Q2Q % growth
743.3M
11.27%
724.05M19.25M2.66%
Q2 2020
Q2Q % growth
682.6M
3.80%
645.71M36.89M5.71%
Q1 2020
Q2Q % growth
707.1M
16.95%
697.6M9.5M1.36%
Q4 2019
Q2Q % growth
691.1M 692.17M-1.07M-0.15%
Q3 2019
Q2Q % growth
668M 679.76M-11.76M-1.73%
Q2 2019
Q2Q % growth
657.6M 669.14M-11.54M-1.72%
Q1 2019
Q2Q % growth
604.6M 601.62M2.98M0.50%
CRL Yearly Revenue VS EstimatesCRL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.04% 5.56% 0.04% 2.92%
Revenue0.04% 2.79% 0.05% 2.05%